SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-17-002552
Filing Date
2017-04-12
Accepted
2017-04-12 16:05:29
Documents
4
Period of Report
2017-05-17
Effectiveness Date
2017-04-12

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2231746zdef14a.htm DEF 14A 282675
2 G507891.JPG g507891.jpg GRAPHIC 16711
3 G23532BGI001.GIF g23532bgi001.gif GRAPHIC 91579
4 G23532BGI002.GIF g23532bgi002.gif GRAPHIC 105598
  Complete submission text file 0001047469-17-002552.txt   578761
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Filer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36020 | Film No.: 17758053
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1